DK0557427T3 - Human rotavira, vacciner og fremgangsmåder - Google Patents

Human rotavira, vacciner og fremgangsmåder

Info

Publication number
DK0557427T3
DK0557427T3 DK92900590T DK92900590T DK0557427T3 DK 0557427 T3 DK0557427 T3 DK 0557427T3 DK 92900590 T DK92900590 T DK 92900590T DK 92900590 T DK92900590 T DK 92900590T DK 0557427 T3 DK0557427 T3 DK 0557427T3
Authority
DK
Denmark
Prior art keywords
hrv
human
rotaviruses
novel
disclosed
Prior art date
Application number
DK92900590T
Other languages
Danish (da)
English (en)
Inventor
Richard L Ward
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Application granted granted Critical
Publication of DK0557427T3 publication Critical patent/DK0557427T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK92900590T 1990-11-16 1991-11-04 Human rotavira, vacciner og fremgangsmåder DK0557427T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61431090A 1990-11-16 1990-11-16
PCT/US1991/008191 WO1992008786A1 (en) 1990-11-16 1991-11-04 Human rotaviruses, vaccines and methods

Publications (1)

Publication Number Publication Date
DK0557427T3 true DK0557427T3 (da) 1998-10-26

Family

ID=24460695

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92900590T DK0557427T3 (da) 1990-11-16 1991-11-04 Human rotavira, vacciner og fremgangsmåder

Country Status (13)

Country Link
US (2) US5474773A (ja)
EP (1) EP0557427B1 (ja)
JP (1) JP2753393B2 (ja)
KR (1) KR0171434B1 (ja)
AT (1) ATE170081T1 (ja)
AU (2) AU9060391A (ja)
BR (1) BR9106982A (ja)
CA (1) CA2096315C (ja)
DE (1) DE69130068T2 (ja)
DK (1) DK0557427T3 (ja)
ES (1) ES2121841T3 (ja)
GR (1) GR3027744T3 (ja)
WO (1) WO1992008786A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
US5773009A (en) * 1994-04-15 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Rotavirus strain G9P11
AU3125795A (en) * 1994-07-11 1996-02-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Attenuated human rotavirus vaccine
ATE248601T1 (de) 1995-06-14 2003-09-15 Baylor College Medicine Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
WO1998017785A1 (fr) * 1996-10-18 1998-04-30 The Research Foundation For Microbial Diseases Of Osaka University Antigenes de rotavirus, vaccins et medicaments servant a diagnostiquer l'infection par rotavirus et leurs procedes de preparation
US6589529B1 (en) * 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
EA005952B1 (ru) 1999-08-17 2005-08-25 Смитклайн Бичем Байолоджикалз С.А. Ослабленная популяция ротавирусов и содержащая ее вакцинная композиция
GB9919468D0 (en) 1999-08-17 1999-10-20 Smithkline Beecham Biolog Vaccine
KR100305188B1 (ko) * 2000-12-26 2001-09-24 정동혁 로타바이러스에 대한 백신
GB0414787D0 (en) * 2004-07-01 2004-08-04 Glaxosmithkline Biolog Sa Method
CN100448485C (zh) * 2003-09-02 2009-01-07 葛兰素史密丝克莱恩生物有限公司 疫苗
JP5588586B2 (ja) 2003-09-02 2014-09-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0503337D0 (en) 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
EA014328B1 (ru) * 2005-08-17 2010-10-29 Глаксосмитклайн Байолоджикалс С.А. Ротавирусная вакцина, индуцирующая гетеротипический перекрестный иммунитет
CN102695522B (zh) 2009-05-12 2016-10-19 美国政府(由卫生和人类服务部、疾病控制和预防中心的部长所代表) 新的人轮状病毒株和疫苗
JP6435259B2 (ja) 2012-05-11 2018-12-05 メディカゴ インコーポレイテッド 植物中でのロタウイルス様粒子の産生
AU2016208999A1 (en) 2015-01-23 2017-07-13 Medicago Inc. Rotavirus-like particle production in plants
GB201614799D0 (en) 2016-09-01 2016-10-19 Glaxosmithkline Biologicals Sa Compositions
CN117737005B (zh) * 2024-01-31 2024-05-14 金宇保灵生物药品有限公司 一株猪轮状病毒毒株及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341870A (en) * 1980-11-19 1982-07-27 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cultivatable human rotavirus type 2
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4571385A (en) * 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
EP0152295B1 (en) * 1984-02-09 1991-03-20 Royal Children's Hospital Research Foundation Live attenuated human rotavirus vaccine and preparation thereof
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4853333A (en) * 1985-07-26 1989-08-01 American Home Products Corporation Production of rotavirus in yeast
US4751080A (en) * 1985-08-26 1988-06-14 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases
US4927628A (en) * 1987-09-21 1990-05-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases and method of preparing same
WO1989006971A1 (en) * 1988-02-01 1989-08-10 The Board Of Trustees Of The Leland Stanford Junio Conserved rotavirus gene segments and use in immunization and neutralization

Also Published As

Publication number Publication date
DE69130068D1 (de) 1998-10-01
GR3027744T3 (en) 1998-11-30
ATE170081T1 (de) 1998-09-15
KR0171434B1 (ko) 1999-02-01
EP0557427A4 (ja) 1995-01-25
BR9106982A (pt) 1993-08-31
US5474773A (en) 1995-12-12
US5695767A (en) 1997-12-09
JPH06505964A (ja) 1994-07-07
JP2753393B2 (ja) 1998-05-20
AU702044B2 (en) 1999-02-11
CA2096315A1 (fr) 1992-05-17
AU9060391A (en) 1992-06-11
DE69130068T2 (de) 1999-01-07
ES2121841T3 (es) 1998-12-16
EP0557427A1 (en) 1993-09-01
AU3787795A (en) 1996-02-29
CA2096315C (en) 1996-11-19
WO1992008786A1 (en) 1992-05-29
EP0557427B1 (en) 1998-08-26

Similar Documents

Publication Publication Date Title
DK0557427T3 (da) Human rotavira, vacciner og fremgangsmåder
DK0755259T3 (da) Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå
EP0192404A3 (en) Vaccine, method for its preparation and use thereof in vaccinating humans against rotavirus infection
ATE242319T1 (de) Deletionsmutanten als impfstoffe gegen cholera
WO2002026250A3 (en) Vaccines for proliferative ileitis
DE69026975T2 (de) Impfstoff gegen Coccidiosis
DE2967036D1 (en) Vaccine and method of making
DK656687D0 (da) Bakterielle antigener, antistoffer, vacciner og fremgangsmaade til fremstilling deraf
US5610059A (en) Etiological agent for porcine enteritis
NL300252I1 (nl) Rotavirus-reassortanten-vaccin.
DE69030099T2 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
DK167599B1 (da) Vaccine til beskyttelse af heste mod kvaerke foraarsaget af streptococcus equi, fremgangsmaade til fremstilling af en stamme af s. equi, som er avirulent for heste, samt s. equi-stamme
IL104382A0 (en) Vaccine containing acemannan as an adjuvant
US3962422A (en) Method for immunizing nursing piglets against transmissible gastroenteritis(TGE) virus
DK0493575T3 (da) Vaccine af reassortant rotavirus
Ward Human rotaviruses, vaccines and method
Yoo et al. Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes: colostral neutralizing antibody by rotavirus VP8
Youmans et al. The relationship between sedimentation value and immunogenic activity of mycobacterial ribonucleic acid
EKUE EPIDEMIOLOGY OF AFRICAN SWINE FEVER IN CAMEROON (SWINE FEVER)
Lovgren Construction and potential of the iscom as immunogen.
DE3109696A1 (de) Verfahren zur herstellung eines als impfstoff geeigneten synthetischen peptids und es enthaltender impfstoff
KR850004398A (ko) 가와사끼병 처리용 왁진, 항원 및 항체
Romero et al. Evaluation of Pasteurella haemolytica immunogens in protection of pneumonic pasteurellosis.]